Home » Topics » pfizer inc

Pfizer, Johnson drop tests for new Alzheimer drug

NEW YORK — Pfizer and Johnson & Johnson said Monday they had given up tests of a new therapy to treat Alzheimer’s disease, saying the treatment did not measure up to expectations. The final, phase 3 trial of the intravenous bapineuzumab therapy did not meet targets for effectiveness in aiding…

FDA approves pneumonia vaccine for adults

(Reuters) – U.S. health regulators approved the expansion of Pfizer Inc’s blockbuster Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. Prevnar 13 is designed to fight 13 forms of a bacterium called Streptococcus pneumoniae, or pneumococcus. Pneumonia caused…